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Abstract  Endoscopic  retrograde  cholangiopancreatography  is  a  very  common  therapeutic  pro-
cedure for  a  variety  of  biliary  and  pancreatic  duct  diseases.  Procedure  related  complications  are
more frequent  than  in  other  endoscopic  procedures.  The  most  common  reported  complications
are pancreatitis,  bleeding,  perforation,  and  infection.  Subcapsular  hepatic  hematoma  sec-Complication;
Hematoma;
Surgery
ondary to  endoscopic  retrograde  cholangiopancreatography  is  a  rare  complication,  but  is
potentially  life-threating.  The  case  is  presented  of  a  25  year  old  patient  with  choledocholithiasis
and cholelithiasis,  who  developed  a  subcapsular  hepatic  hematoma.  The  patient  presented  with Endoscopy magazine is the only magazine in which the work under review is published.
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an  acute  rupture  of  Glisson’s  capsule,  which  was  successfully  managed  with  surgical  treatment.
A review  of  the  literature  is  presented,  which  consists  of  30  cases.
© 2016  ASOCIACIO´N  MEXICANA  DE  ENDOSCOPIA  GASTROINTESTINAL  A.C.  Published  by  Masson










Hematoma  subcapsular  hepático:  una  complicación  post-CPRE  poco  frecuente  pero
potencialmente  mortal.  Reporte  de  caso  y  revisión  de  la  literatura
Resumen  La  colangiopancreatografía  retrógrada  endoscópica  es  actualmente  un  proced-
imiento  terapéutico  muy  común  para  el  manejo  de  enfermedades  biliopancreáticas.  Las
complicaciones  secundarias  a  este  procedimiento  son  más  frecuentes  que  en  otros  procedimien-
tos endoscópicos,  dentro  de  las  cuales  la  pancreatitis,  hemorragia,  perforación  e  infección  son
las que  se  presentan  más  a  menudo.  El  hematoma  hepático  subcapsular  secundario  a  colan-
giopancreatografía  retrógrada  endoscópica  es  una  complicación  muy  rara,  sin  embargo  esta
puede poner  en  peligro  la  vida  del  paciente.  Presentamos  el  caso  de  una  paciente  de  25  an˜os  con
coledocolitiasis  y  colelitiasis  que  desarrolló  un  hematoma  hepático  subcapsular  poscolangiopan-
creatografía  retrógrada  endoscópica  con  abdomen  agudo  y  ruptura  de  la  cápsula  de  Glisson  que
fue manejada  exitosamente  con  tratamiento  quirúrgico,  así  como  una  revisión  de  la  literatura
de 30  casos.
©  2016  ASOCIACIO´N  MEXICANA  DE  ENDOSCOPIA  GASTROINTESTINAL  A.C.  Publicado  por  Masson








































ndoscopic  retrograde  cholangiopancreatography  (ERCP)  is
idely  available  in  most  hospitals  and  is  one  of  the
ost  frequently  performed  procedures  in  the  treatment
f  biliary--pancreatic  diseases.  Even  in  centers  with  a
igh-volume  of  patients  that  present  with  biliary  and  pan-
reatic  pathology  and  are  subsequently  treated,  serious
omplications  from  therapeutic  ERCP  can  occur  in  2.5--8%
f  cases,  with  mortality  ranging  from  0.5%  to  1.0%.1,2
cute  pancreatitis,  cholangitis,  hemorrhage,  and  perfora-
ion,  the  leading  complications  in  1--7%,  1.4%,  1%,  and  1%
f  patients  treated  via  ERCP  respectively.2,3 Subcapsular
epatic  hematoma  is  a  rare  complication  following  ERCP
nd  can  be  life-threatening  in  some  cases.4 The  purpose
f  our  study  is  to  present  a  case  of  post-ERCP  subcap-
ular  hepatic  hematoma  which  evolved  with  hypovolemic
hock  and  required  surgical  intervention;  we  also  review
he  possible  pathophysiological  mechanisms  underlying  such
omplication  and  analyze  the  sum  of  the  contemporary
vailable  literature  (Table  1).
ase report
 25-year-old  female  with  a  history  of  pregnancy  and  C  sec-
ion  7  months  prior  to  admission  presented  with  recurrent
bdominal  pain  in  the  upper  right  quadrant  15  days  prior
dmission,  the  pain  was  accompanied  by  nausea,  vomitit-
ng,  and  jaundice.  Laboratory  report  showed  the  following:
BC  5.51  ×  1.000/L,  Hemoglobin  11.5  g/dL,  platellet




gigure  1  ERCP  obtaining  one  yellow  round  bile  duct  stone  of
 mm  of  diameter.
nternational  normalized  ratio  1.16,  aspartate  aminotrans-
erase  128  U/L,  alanine  aminotransferase  125  U/L,  Total
ilirubin  3.57  mg/dL,  Direct  Bilirubin  2.96  mg/dL,  alkaline
hosphatase  928  U/L.  An  MRCP  revealed  intra  and  extrahe-
atic  bile  duct  dilation  with  a  defect  in  the  distal  portion
f  the  common  bile  duct.  ERCP  with  biliary  sphincterotomy
ver  a  0.035-inch  diameter  guidewire  was  performed,  can-
ulation  of  the  papilla  on  a  ﬁrst  attempt  without  difﬁculty
ollowing  the  insertion  of  a  16  mm  stone  extraction  balloon
atheter  (Shaili  Endoscopy®) obtaining  one  yellow  round  bile
uct  stone  of  5  mm  of  diameter  (Fig.  1),  control  cholan-










Table  1  Hepatic  subcapsular  hematoma  after  ERCP  summary  of  cases.






De  la  Serna
et  al.,1,6,8
71  F  Yes Sphyncterotomy  +  stone  extraction None  CT  No  48  h
Horn et  al.1,6,8 88  F  Yes Biliary  brushing  +  stent  10  Fr  ×  7  cm Systemic  hypertension  +  cholecystectomy NA  No  48  h
Cardenas  et  al1,6,8 54  M  Yes Sphyncterotomy  +  stent  10  Fr  ×  7  cm Orthotopic  liver  transplant CT  No  24  h
Gonzalez  et  al2 30  F  NA  Spyncterotomy  +  biliary  ballon
dilation  +  stent  10  Fr
None  NA  No  72  h
Oliveira et  al7 84  M  NA  Stone  extraction COPD  +  pulmonary
thromboembolism  +  anticoagulation
CT  No  10  days
Chi et  al1,6,8 43  F  Yes Sphyncterotomy  +  metalic
stent  +  biliary  balloon  dilation  20  mm
Cholecystectomy  +  pancreatic  cancer CT  Yes 5  h
McArthur  et  al1,6,8 71  M  Yes Sphyncterotomy  +  stone
extraction  +  stent  7  Fr
None  CT  No  12  h
Baudet et  al1,6 69  F  Yes Sphyncterotomy  +  stone  extraction None  CT  Yes 48  h
Del Rosi  et  al9 28  F  Yes Sphyncterotomy  +  stone
extraction  +  stent  10  Fr  ×  10  cm
Cholecystectomy  CT  No  48  h
Carrica et  al4 37  F  Yes Sphyncterotomy  +  stone  extraction Cholecystectomy  MRI  No  72  h
Bartolo et  al3 66  F  NA  Sphyncterotomy  +  stone  extraction  None  NA  No  Immediate
Priego et  al1,6 30  F  NA  Sphyncterotomy  None  CT  No  Immediate
Revuelto et  al1,6,8 41  NA  NA  Sphyncterotomy  +  stone  extraction NA  CT  No  NA
Del Pozo  et  al1,6 76  F  Yes  Sphyncterotomy  +  stone  extraction  Atrial  ﬁbrillation  +  anticoagulation  NA  No  6  h
Bhati et  al1,6,8 51  F  Yes  Sphyncterotomy  +  stone  extraction  None  CT  Yes  Immediate
Fei et  al1,6 56  M  Yes Sphyncterotomy  +  stone  extraction None  CT  No  72  h
Zizzo et  al1 52  F  Yes  Sphyncterotomy  +  stone  extraction  None  CT  No  24  h
Klímová  et  al6 52  M  Yes Sphyncterotomy  +  stone  extraction Chronic  pancreatitis  CT  No  6  h
Perez et  al1,6 72  F  NA  Sphyncterotomy  +  stone  extraction Diabetes  mellitus  +  systemic  hypertension NA  Yes 2  h
Orellana  et  al1 96  NA  NA  Ampullary  biopsies  +  stent  Periampullary  tumor  CT  No  4  h
Orellana  et  al1,6 49  M  NA  Biliary  stent  replacement Testicular  cancer  +  acute  pancreatitis CT  Yes 2  h
Orellana  et  al1,6 55  F  NA  Biliary  stent  replacement  Gallbladder  cancer  CT  No  NA
Papachristou  et  al8 69  M  Yes  Billiary  balloon
dilation  +  brushing  +  ampullary
biopsies  +  stent
Primary  sclerosing  cholangitis  CT  NA  48  h
De Mayo  et  al8 96  M  NA  Sphyncterotomy  +  stent Acute  pancreatitis CT  No  4  h
Nari et  al1,6,8 15  F  NA  NA  None  US  No  NA
Ortega et  al1,6,8 81  M  NA  Sphyncterotomy  +  stone  extraction  NA  NA  NA  NA
Bhandarkar  et  al8 64  F  NA  NA  NA  NA  NA  10  days
Ertugrul et  al1,6,8 41  M  Yes Stent  Colangiocarcinoma  CT  No  48  h
Petit et  al1,6,8 98  M  Yes  Sphyncterotomy  +  stone  extraction  Acute  myocardial  infarction  +  parcial
gastrectomy  sec.  to  peptic  ulcer  disease
CT NA  48  h
Poon et  al10 79  F  NA  Sphyncterotomy  +  stent  Stroke  +  congestive  heart  failure  CT  No  Immediate










Table  1  (Continued  )
Reference  Age  Sex  Clinical  manifestacions  Treatment  Antibiotics  Hemoglobin
decrease  (g/dL)
Death
De  la  Serna
et  al.,1,6,8
71  F  RUC  pain  Conservative  Yes  NA  No
Horn et  al.1,6,8 88  F  RUC  pain  +  anemia  Conservative  Yes  NA  No
Cardenas  et  al1,6,8 54  M  Mesogastric  abdominal  pain  Conservative  Yes  3.2  g/dL  No
Gonzalez  et  al2 30  F  RUC  pain  Surgery  Yes  NA  Yes
Oliveira  et  al7 84  M  RUC  pain  Percutaneous  drainage  Yes  3.3  g/dL  Yes
Chi et  al1,6,8 43  F  RUC  pain  +  anemia  Embolization  Yes  NA  No
McArthur  et  al1,6,8 71  M  RUC  pain  Conservative  Yes  NA  No
Baudet et  al1,6 69  F  RUC  pain  +  fever  Embolization  +  surgery  Yes  CF  7.3  g/dL  No
Del Rosi  et  al9 28  F  RUC  pain  Conservative  Yes  7.3  g/dL  No
Carrica et  al4 37  F  RUC  pain  Percutaneous  drainage  Yes  CF  1.3  g/dL  No
Bartolo et  al3 66  F  Hypotension  +  tachycardia  Surgery  No  10.3  g/dL  Yes
Priego et  al1,6 30  F  RUC  pain  Surgery  Yes  NA  No
Revuelto  et  al1,6,8 41  NA  Anemia  Conservative  Yes  NA  No
Del Pozo  et  al1,6 76  F  RUC  pain  Conservative  Yes  NA  No
Bhati et  al1,6,8 51  F  RUC  pain  +  hypotension  Percutaneous  drainage  NA  NA  No
Fei et  al1,6 56  M  RUC  pain  Percutaneous  drainage  Yes  NA  No
Zizzo et  al1 52  F  Epigastric  pain  Embolization  Yes  3.3  g/dL  No
Klímová  et  al6 52  M  RUC  pain  Embolization  Yes  6  g/dL  No
Perez et  al1,6 72  F  RUC  pain  Surgery  NA  NA  No
Orellana  et  al1 96  NA  Right  omalgia  Conservative  Yes  NA  No
Orellana  et  al1,6 49  M  RUC  pain  Embolization  NA  NA  No
Orellana  et  al1,6 55  F  RUC  pain  +  right  omalgia  Conservative  NA  NA  No
Papachristou  et  al8 69  M  RUC  pain  +  right  omalgia  +  anemia  Conservative  NA  3.5  g/dL  NA
De Mayo  et  al8 96  M  Right  omalgia  Conservative  Yes  NA  No
Nari et  al1,6,8 15  F  RUC  pain  +  right  omalgia  +  hypotension  Conservative  Yes  NA  No
Ortega et  al1,6,8 81  M  RUC  pain  Percutaneous  drainage  Yes  NA  NA
Bhandarkar  et  al8 64  F  RUC  pain  +  fever  +  anemia  Percutaneous  drainage  NA  NA  NA
Ertugrul  et  al1,6,8 41  M  RUC  pain  +  fever  Conservative  Yes  NA  No
Petit et  al1,6,8 98  M  RUC  pain  +  asthenia  Percutaneous  drainage  NA  NA  NA
Poon et  al10 79  F  RUC  pain  +  hypotension  Conservative  NA  5  g/dL  No
Case report  25  F  RUC  pain  +  anemia  Surgery  Yes  4.2  g/dL  No
F -- female, M -- male, COPD -- Chronic Obstructive Pulmonary Disease, RUC -- right upper cuadrant, CT -- computed tomography, US -- ultrasound, MRI -- magnetic resonance image, NA --
not available, CF -- Citrobacter freundii.
Subcapsular  hepatic  hematoma  after  ERCP  79
Figure  3  Rupture  of  Glisson’s  capsule  observed  in
laparotomy.
Figure  4  Subcapsular  hepatic  hematoma  of










5Figure  2  Upper  endoscopy  with  duodenoscope  without  evi-
dence  of  bleeding  from  sphyncterotomy.
was  ﬁnished  without  evident  complications  such  as  bleed-
ing  or  injury.  12  h  post  procedure  the  patient  developed
right  upper  quadrant  abdominal  pain,  hemoglobin  dropped
4  g/dL  (Hb  7.3  g/dL),  amylase  spiked  to  162  U/L  and  lipase
also  showed  a  rise  to  213  U/L.  There  was  no  clinical  evi-
dence  of  gastrointestinal  bleeding.  An  upper  endoscopy
was  performed  with  a  frontal  video  endoscope  and  a  duo-
denoscope  without  evidence  of  gastrointestinal  bleeding  or
post-sphyncterotomy  bleeding  (Fig.  2).  Three  packed  red
blood  cells  (PRBCs)  were  transfused,  and  a  12  h  post  transfu-
sional  hemoglobin  was  obtained  which  reported  10.3  g/dL.
Hemoglobin  declined  to  5.3  g/dL  3  days  after  ERCP.  The
patient  developed  grade  4  hypovolemic  shock  with  acute
abdomen  and  positive  Blumberg  sign.  An  urgent  abdominal
ultrasound  revealed  free  ﬂuid  in  the  abdominal  cavity.  Two
more  PRBCs  were  transfused  and  an  urgent  laparotomy  was
performed  observing  rupture  of  Glisson’s  capsule  (Fig.  3)
and  approximately  3000  ml  of  blood  in  the  peritoneal  cav-
ity  was  found.  Abdominal  packing  was  performed  and  two
more  PRBCs  were  transfused  during  surgery.  The  patient  was
admitted  to  the  Intensive  Care  Unit  (ICU)  where  she  had  to
have  assisted  breathing  via  endotracheal  tube.  There  was
no  need  for  vasoactive  support.  48  h  later  a  second  laparo-
tomy  was  performed  to  unpack  the  abdomen.  The  patient
was  extubated  6  days  after  the  ﬁrst  laparotomy  and  was  dis-
charged  from  the  ICU.  The  patient  evolved  well,  maintaining
hemoglobin  levels  at  10.9  g/dL  and  was  discharged  from  the
hospital  16  days  after  the  ERCP  procedure.  One  month  later
a  follow-up  MRI  demonstrated  a  remanent  heterogenic  sub-
capsular  hepatic  hematoma  of  15.2  ×  10.4  ×  3.6  cm  in  the
right  hepatic  lobe  (Fig.  4).  Currently,  the  patient  is  (3  months
post  ERCP)  generally  well  and  reports  slight  abdominal  dis-
comfort,  patient  surveillance  will  continue  until  complete
resolution  of  the  hematoma  is  observed.
DiscussionBleeding  related  to  an  ERCP  procedure  is  usually  due
to  endoscopic  sphincterotomy.  Bleeding  seen  endoscopi-




pesonance  imaging  (MRI)  one  month  after  presentationT2W
equence  on  a  1.5-T  MRI  machine.
ncommon, but  is  generally  not  considered  an  adverse  event
nless  there  is  signiﬁcant  blood  loss,  which  is  manifested  as
vident  hypovolemia  and/or  that  has  a  need  for  transfusion.
hen  applying  clinical  criteria  such  as  melena,  hemateme-
is,  a  drop  greater  than  2  g/dL  in  hemoglobin  level,  or
equirement  for  secondary  intervention  such  as  endoscopy
r  blood  transfusion,  the  overall  incidence  of  bleeding  is
round  0.1--2%  even  in  experienced  hands. Subcapsular
epatic  hematoma  is  a  rare  and  exceptional  event,  of  which
nly  30  cases  have  been  reported  since  2000.  The  patho-





































































ematoma  is  not  clearly  deﬁned,  however  various  authors
gree  that  vascular  injury  of  small-caliber  intrahepatic  ves-
els  secondary  to  guidewire  use  may  be  the  cause,  which
ay  also  explain  the  presence  of  free  air  and  development
f  infections  in  some  of  the  cases.1,6
atient  factors
e  found  that  the  median  age  of  presentation  is  59  (15--98)
ears,  with  58%  female  and  35%  male  distribution.  Only  2
6.4%)  patients  had  a  history  of  anticoagulation  therapy  prior
o  the  procedure.  Almost  half  of  the  patients  (48.3%)  pre-
ented  clinical  manifestations  in  the  ﬁrst  24  h  post-ERCP.  The
ost  common  manifestation  was  abdominal  pain  in  87%;  in
ome  case  reports  fever  was  mentioned  to  be  one  of  the  pri-
ary  manifestations,  but  we  found  that  right  omalgia  and
linical  manifestations  of  hypovolemic  shock  (tachycardia
r  hypotension)  were  present  more  often  9.6%  vs  16.1%  vs
2.9%.
rocedure  factor
n  17  (54.8%)  cases  the  use  of  a  guide  wire  was  reported,
ut  we  cannot  exclude  its  use  on  the  other  14  cases.  The
iterature  on  these  14  cases  does  not  mention  the  use  of  a
uide  wire.
In  most  of  the  cases,  67.7%,  diagnosis  was  performed
y  CT,  but  the  use  of  US  and  MRI  was  also  described  in  2
nd  1  cases  respectively.  In  our  case  report  abdominal  US
as  performed  searching  for  free  ﬂuid  in  the  abdominal
avity,  because  of  the  development  of  an  acute  abdomen.
n  almost  half  of  the  patients  (45.1%)  no  invasive  treat-
ent  was  required.  Percutaneous  drainage  was  performed
n  7  (22.5%),  surgery  in  6  (19.3%),  and  embolization  in  4
12.9%)  patients.  Only  2  case  reports  described  the  pathogen
ound  in  the  hematoma  culture,  both  found  Citrobacter  fre-
ndii,  which  is  a  facultative  aerobic  gram-negative  bacilli  of
he  Enterobacteriaceae  family,  commonly  found  in  the  gas-
rointestinal  tract.  In  22  (70.9%)  patients  antibiotics  where
sed,  either  as  a  prophylactic  measure  or  as  treatment  for
nfection,  8  (25.8%)  did  not  specify  whether  they  used  antibi-
tics  or  not.  Only  11  case  reports  mention  a  decrease  in
emoglobin  that  went  between  1.3  g/dL  to  10.3  g/dL,  and
rom  those  cases,  the  majority,  63%,  required  some  kind
f  intervention  (embolization,  percutaneous  drainage  or
urgery),  concluding  that  hemoglobin  decrease  is  a  good  pre-
ictor  for  requiring  intervention,  no  association  was  found
etween  hemoglobin  drop  and  the  need  of  a  speciﬁc  kind  of
ntervention.  3  (9.6%)  deaths  were  reported,  2  patients  who
equired  surgery  and  one  in  whom  percutaneous  drainage
as  performed.
Because  of  the  mortality  rate  found  in  the  literature  it
s  important  to  consider  this  as  a  life-threatening  adverse
vent.  Another  rare  complication  following  ERCP  that  can
ave  a  similar  presentation  as  described  in  the  case  report
s  injury  to  the  spleen  causing  intraperitoneal  hemorrhage
ith  a  few  cases  being  reported  in  the  literature.  Symptoms
ften  include  localized  peritoneal  irritation  in  the  left  upper
1A.  García  Tamez  et  al.
uadrant  progressing  with  time  to  generalized  peritonitis,
long  with  referred  pain  to  the  left  shoulder.  Changes  in
ital  signs  including  tachycardia  and  orthostatic  changes  in
lood  pressure  are  frequent.
onclusions
ubcapsular  hepatic  hematoma  is  a  rare  condition  associ-
ted  to  ERCP  that  must  be  suspected  when  abdominal  pain
s  present  after  the  procedure,  it  may  have  a  fatal  course  if
t  is  not  diagnosed  and  treated  early.  Further  publications  of
ase  reports  will  help  establish  risk  factors  and  appropriate
reatment.
inancing
o  funding  was  received  for  this  work.
onﬂict of interests
uthors  declare  no  conﬂict  of  interests  for  this  article.
eferences
1. Zizzo M, Lanaia A, Barbieri I, et al. Subcapsular hepatic
hematoma after endoscopic retrograde cholangiopancreatog-
raphy a case report and review of literature. Medicine
(Baltimore). 2015;94:1--4.
2. González R, Garcia E, Espinosa O, et al. Tratamiento quirúrgico
para hematoma subcapsular hepático posterior a colangiografía
retrógrada endoscópica; caso inusual. Cirugía y Cirujanos.
2015;67:1--4.
3. Bartolo EF, Endoqui Y, Trejo J, et al. Hematoma hep-
ático subcapsular roto y choque hipovolémico como una
complicación inusual tras la realización de colangiopancre-
atografía retrógrada endoscópica. Reporte de un caso. Cir Gen.
2012;34:217--20.
4. Carrica SA, Belloni R, Baldoni F. Hematoma intraparenquimatoso
hepático postcolangiopancreatografía retrógrada endoscópica
sobreinfectado por Citrobacter freundii y Klebsiella pneumo-
niae BLEE. Acta Gastroenterol Latinoam. 2014;44:125--8.
5. Rustagi T, Jamidar PA. Endoscopic retrograde
cholangiopancreatography-related adverse events general
overview. Gastrointest Endoscopy Clin N Am. 2015;25:97--106.
6. Klímová K, Padilla C, González C, et al. Subcapsular hepatic
hematoma after ERCP: a case report and revision of literature.
Sci Res. 2014;3:161--6.
7. Oliveira A, Tato R, Velosa J. Infected hepatic hematoma 10 days
after ERCP. Endoscopy. 2013;45:E1--2.
8. Baudet JS, Arguin˜arena X, Redondo I, et al. Subcapsular
hepatic hematoma: an uncommon complication of endoscopic
retrograde cholangiopancreatography. Gastroenterol Hepatol.
2011;34:79--82.
9. Del Rosi M, Martinez Y, Louis CE, et al. Hematoma intrahepático
y subcapsular posterior a colangiopancreatografía retrógrada
endoscópica (CPRE). Reporte de un caso y revisión. GEN.
2007;61:210--1.
0. Poon CM, Lee FY, Ko CW, et al. A rare complication of
intra-abdominal hematoma after ERCP. Gastrointest Endosc.
2002;56:307.
